Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|
| Total revenue | 7.54%23.53B | 21.88B |
| Cost of revenue | 7.03%16.87B | 15.76B |
| Gross profit | 8.83%6.66B | 6.12B |
| Operating expense | 5.45%4.49B | 4.25B |
| Operating profit | 16.53%2.18B | 1.87B |
| Net non-operating interest income (expenses) | -65.52%4.62M | 13.4M |
| Non-operating interest income | -53.44%7.2M | --15.47M |
| Non-operating interest expense | 24.90%2.58M | --2.07M |
| Net investment income | -231.79%-13.55M | 10.28M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||
| Income from associates and other participating interests | 98.66%-3.46M | -258.36M |
| Special income (charges) | 60.03%-2.36M | -5.92M |
| Less:Other special charges | -60.03%2.36M | --5.92M |
| Other non-operating income (expenses) | 14.15%13.97M | 12.24M |
| Income before tax | 32.71%2.18B | 1.64B |
| Income tax | 27.99%659.83M | 515.53M |
| Net income | 34.88%1.52B | 1.12B |
| Net income continuous operations | 34.88%1.52B | --1.12B |
| Noncontrolling interests | 16.80%24.16M | 20.68M |
| Net income attributable to the company | 35.22%1.49B | 1.1B |
| Preferred stock dividends | ||
| Other under preferred stock dividend | 0 | 0 |
| Net income attributable to common stockholders | 35.22%1.49B | 1.1B |
| Gross dividend payment | ||
| Basic earnings per share | 35.22%125.73 | 92.9806 |
| Diluted earnings per share | 35.06%125.58 | 92.9806 |
| Dividend per share | 63 | |
| Currency Unit | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP |